DNMDP
DNMDP, a phosphodiesterase 3A (PDE3A) inhibitor, is a potent and selective cancer cell cytotoxic agent. DNMDP binding to PDE3A promotes an interaction between PDE3A and Schlafen 12 (SLFN12) . DNMDP shows clear cell-selective cytotoxicity[1].
Product Specifications
CAS Number
328104-79-6
UNSPSC
12352005
Target
Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dnmdp.html
Purity
99.46
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
[O-][N+](C1=CC(C(C(C)C2)=NNC2=O)=CC=C1N(CC)CC)=O
Molecular Formula
C15H20N4O3
Molecular Weight
304.34
References & Citations
[1]de Waal L, et al. Identification of cancer-cytotoxic modulators of PDE3A by predictive chemogenomics. Nat Chem Biol. 2016 Feb;12 (2) :102-8.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PDE3
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
PE-Linked Monoclonal Antibody to Tissue Factor Pathway Inhibitor (TFPI)
PE-Linked Monoclonal Antibody to Tissue Factor Pathway Inhibitor (TFPI)
PE-Linked Monoclonal Antibody to Tissue Factor Pathway Inhibitor (TFPI)